Washington, D.C. (Thursday, June 13, 2024) – In a decision that comes right smack in the middle of the presidential race, the U.S. Supreme Court today preserved access to the widely used abortion medication mifepristone.
![](https://whur.com/wp-content/uploads/2014/03/20140320__p_d9df3224-7b8e-4b23-967e-446cc065b691lsoriginalph.jpg)
Justices ruled that anti-abortion opponents lacked the legal right to sue over the Food and Drug Administration’s approval of the drug. The decision comes nearly two years after the high court’s decision to overturn Roe v. Wade.
Mifepristone is used in nearly two thirds of all abortions in the U.S. Justice Brett Kavanaugh wrote for the court saying that “federal courts are the wrong forum for addressing the plaintiffs’ concerns about FDA’s actions.”
President Biden praised today’s decision. But added “it does not change the fact that the fight for a woman to get the treatment she needs is imperiled if not impossible in many states.”